Robert F. Kennedy Jr. Reverses FDA Peptide Ban: What It Means for Public Health
Health Secretary Robert F. Kennedy Jr. has reversed the FDA’s 2023 ban on compounding certain peptides, including BPC-157 and GHK-Cu. Critics warn thi...
Health Secretary Robert F. Kennedy Jr. has reversed the FDA’s 2023 ban on compounding certain peptides, including BPC-157 and GHK-Cu. Critics warn thi...
Gwyneth Paltrow’s recent comments about peptides reveal a gap between celebrity-endorsed wellness trends and scientific understanding. From subway ads...
Peptides are gaining popularity for weight loss, skin health, and anti-aging, but their legality and safety are often unclear. With growing demand and...
Robert F. Kennedy Jr.'s campaign to ease federal restrictions on peptides could trigger a massive wellness trend, benefiting telehealth firms, compoun...
The FDA banned 19 peptide drugs for compounding pharmacies in 2023 due to safety concerns. Now, under HHS Secretary RFK Jr., the agency may reverse th...